AOD-9604 is on the World Anti-Doping Agency Prohibited List under category S2.2 (peptide hormones, growth factors, related substances, and mimetics)
No, there is no scientific evidence that B12 injections promote fat loss in individuals with normal B12 levels
Connected Care B12 can connect to weight loss, IV therapy, hormone optimization, or broader wellness planning when appropriate
The clinical evidence overwhelmingly favors semaglutide for meaningful fat reduction, but the nearly nonexistent side effect profile of AOD 9604 gives it a unique position for specific use cases
- Liver enzymes if any preexisting liver concern, given the monkey toxicology signal
This distinction allows researchers to explore upstream metabolic regulation and cellular signaling mechanisms through a different experimental approach